Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care

Clinical trial NCT07096934 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07096934
Sponsor: FibroBiologics
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetic Foot Ulcer (DFU)

Start date: 2025-09-01
Primary completion: 2026-03-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.